Loading AUPH charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading AUPH comparable companies…
| AUPHAurinia Pharmaceuticals Inc.(opens in a new tab) | $2.25B | $0.32B | +21.0% | 90.6% | 48.6% | 7.00× | 7.3× |
|---|---|---|---|---|---|---|---|
| ARVNArvinas, Inc.(opens in a new tab) | $0.52B | $0.32B | −15.0% | — | −5.7% | 1.63× | 32.7× |
| EOLSEvolus, Inc.(opens in a new tab) | $0.48B | $0.32B | +13.9% | 66.7% | −5.9% | 1.53× | — |
| XERSXeris Biopharma Holdings, Inc.(opens in a new tab) | $1.85B | $0.34B | +36.3% | 86.6% | 10.9% | 5.52× | — |
| AVIRAtea Pharmaceuticals, Inc.(opens in a new tab) | $0.33B | $0.35B | +622.5% | — | — | — | — |
| Medianpeers, excl. AUPH | $0.50B | $0.33B | +25.1% | 76.7% | −5.7% | 1.63× | 32.7× |